Psychiatrist Shortages and the Expanding Role of Primary Care in Depression Treatment

By Dr. David Caldwell, Founder of MiNDSET Integrative Ketamine Care

Mental health disorders such as depression and anxiety continue to rise across the United States, yet the number of psychiatrists available to provide specialized care has not kept pace. Today, more than 75% of antidepressant prescriptions in the U.S. are written by primary care providers (PCPs) rather than psychiatrists. This reality reflects a national shortage of psychiatric specialists—a challenge that is acutely felt in states like Alabama.

The gap has profound implications for how treatment-resistant depression (TRD) is diagnosed, treated, and managed, especially when considering advanced therapies such as ketamine infusion therapy (KIT).

The Psychiatric Workforce Gap

The American Psychiatric Association has consistently reported that the U.S. faces a shortage of thousands of psychiatrists, with nearly 60% of counties nationwide lacking even a single practicing psychiatrist. Alabama, like many other states, is not immune to this shortage. Patients may wait months for an appointment, leaving primary care physicians as the de facto front line in diagnosing and prescribing treatment for depression.

This shortage places significant responsibility on PCPs, who often manage complex cases without the benefit of psychiatric consultation. While many patients benefit from traditional antidepressants, roughly one-third do not respond—highlighting the urgent need for access to evidence-based alternatives.

Alabama’s Position on Ketamine

In Alabama, the State Board of Medical Examiners has issued clear guidance: ketamine can only be prescribed by a licensed physician, and if the physician is not a psychiatrist, the diagnosis of TRD must first be confirmed by a psychiatrist.

This requirement underscores two realities:

1. Psychiatrists are scarce, yet their expertise remains critical in confirming complex mental health diagnoses.

2. Primary care providers remain central to patient care, since they are often the ones identifying depression, trialing multiple medications, and referring patients for advanced treatments.

The challenge is that without enough psychiatrists, patients may face unnecessary delays in accessing therapies that could transform their lives.

The Role of Integrative Ketamine Care

At MiNDSET Integrative Ketamine Care, we see firsthand the difference that timely access to treatment can make. For patients who have cycled through multiple antidepressants without success, ketamine infusion therapy offers rapid relief, often within 24 hours.

But ketamine therapy is not just about the infusion. By combining KIT with psychotherapy, we amplify and sustain results, achieving success rates close to 90%—well above national averages. This integrative model also helps fill the gap left by psychiatrist shortages, ensuring that patients receive comprehensive care that addresses both biology and psychology.

Conclusion

Alabama does not have a secret surplus of psychiatrists. Like the rest of the nation, it faces a shortage that impacts how depression is treated every day. Primary care physicians shoulder most of the prescribing responsibility, but innovative clinics like MiNDSET are helping bridge the gap—providing access to advanced therapies within a safe, integrated, physician-led model.

The future of mental health care depends on acknowledging this shortage, expanding treatment options, and embracing models of care that combine medical innovation with psychological support.